BridgeBio Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018
Market Capitalization	4,608	7,023	1,139	2,455	8,716	4,331	-
Market Cap Growth	-	516.56%	-53.60%	-71.84%	101.23%	-	-
Enterprise Value	5,896	8,311	2,353	3,344	8,605	3,877	-382
PE Ratio	-10.92	-10.92	-2.37	-4.36	-19.42	-16.62	-
PS Ratio	495.28	754.92	14.67	35.21	1056.59	106.79	-
PB Ratio	-5.19	-5.19	-0.91	-2.82	150.52	10.60	-
P/FCF Ratio	-13.28	-13.28	-3.62	-4.80	-21.40	-16.90	-
P/OCF Ratio	-13.31	-13.31	-2.72	-4.93	-21.81	-17.08	-
EV/Sales Ratio	633.76	893.41	30.30	47.97	1043.10	95.59	-
EV/EBITDA Ratio	-15.07	-15.07	-6.05	-6.63	-21.11	-15.45	2.98
EV/EBIT Ratio	-14.79	-14.79	-5.87	-6.48	-20.88	-15.40	2.98
EV/FCF Ratio	-15.71	-15.71	-7.49	-6.54	-21.13	-15.13	2.75
Debt / Equity Ratio	-1.28	-1.28	-1.37	-1.98	8.56	0.22	0.17
Debt / EBITDA Ratio	-3.16	-3.16	-4.43	-3.42	-1.22	-0.37	-0.43
Debt / FCF Ratio	-3.29	-3.29	-5.48	-3.38	-1.22	-0.36	-0.39
Quick Ratio	3.15	3.15	4.34	6.34	6.35	9.09	13.39
Current Ratio	3.32	3.32	4.52	6.58	6.72	9.42	13.67
Asset Turnover	0.02	0.02	0.10	0.07	0.01	0.08	0
Interest Coverage	-6.91	-6.91	-4.98	-11.03	-11.24	-28.73	-50.33
Return on Equity (ROE)	50.00%	50.00%	43.20%	91.00%	-206.80%	-339.10%	-103.20%
Return on Assets (ROA)	-110.40%	-110.40%	-63.60%	-56.70%	-53.00%	-52.10%	-46.40%
Return on Capital (ROIC)	-157.52%	-157.52%	-109.22%	-67.38%	-85.69%	-53.22%	-49.72%
Earnings Yield	-13.96%	-9.16%	-42.24%	-22.92%	-5.15%	-6.02%	-
FCF Yield	-11.48%	-7.53%	-27.59%	-20.82%	-4.67%	-5.92%	-
Buyback Yield / Dilution	-10.39%	-10.39%	-2.16%	-22.34%	-12.27%	-70.15%	-101.86%
Total Shareholder Return	-10.39%	-10.39%	-2.16%	-22.34%	-12.27%	-70.15%	-101.86%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).